PACB
PACB
NASDAQ · Life Sciences Tools & Services

Pacific Biosciences Of Calif

$1.40
-0.08 (-5.41%)
As of Aug 8, 1:52 AM ET ·
Analyst Consensus
Buy
14
Analysts
Moderate
Coverage
Buy 9 64%
Hold 4 29%
Sell 1 7%
Price Target
Analyst Price Target +3,250.0% upside
Low Target $34.06
Average Target $46.90
High Target $60.93
Current Price $1.40
Current
$1.40
Target
$46.90
$34.06 $46.90 avg $60.93
Scenario Analysis
Bear Case
$34.06
2,332.9%
Low target
Base Case
$46.90
+3,250.0%
Avg target
Bull Case
$60.93
+4,252.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$2.73
-48.7% from high
52-Week Low
$1.09
+28.4% from low
Target vs 52W High
$46.90
+1,617.9% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 36 81% $369.21 -37.8%
DHR
Danaher Corp
Strong Buy 32 84% $158.11 -22.8%
A
Agilent Technologies Inc
Strong Buy 29 79% $64.69 -55.7%
WAT
Waters Corp
Hold 30 53% $189.60 -53.4%
IQV
Iqvia Holdings Inc
Strong Buy 29 76% $82.96 -65.2%
ILMN
Illumina Inc
Buy 28 61% $169.36 -9.9%
MTD
Mettler-Toledo International
Hold 20 50% $170.43 -88.1%
WST
West Pharmaceutical Services
Strong Buy 22 91% $136.24 -61.5%